With appeals court ruling, Biogen escapes renewed fight over Tecfidera patient death
admin 16th May 2017 Uncategorised 0After a patient taking Biogen’s Tecfidera died in 2014, the hot MS drug was slapped with a new FDA warning, lost ground in the marketplace—and soon, Biogen faced a securities lawsuit claiming it hid the negative fallout. Now, with a new ruling at the 1st Circuit Court of Appeals, Biogen has put that action to rest.
More: With appeals court ruling, Biogen escapes renewed fight over Tecfidera patient death
Source: fierce